ProPhase Labs, Inc.
PRPH
$0.3396
-$0.0107-3.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.36M | -27.76M | -26.31M | -23.60M | -16.78M |
| Total Depreciation and Amortization | 6.64M | 7.74M | 7.14M | 6.89M | 6.47M |
| Total Amortization of Deferred Charges | 1.49M | 1.04M | 469.00K | 258.00K | 132.00K |
| Total Other Non-Cash Items | 12.81M | 4.33M | 4.69M | 5.41M | 5.01M |
| Change in Net Operating Assets | 14.89M | -74.00K | -1.33M | -6.45M | -6.72M |
| Cash from Operations | -17.54M | -14.72M | -15.34M | -17.48M | -11.89M |
| Capital Expenditure | -906.00K | -1.38M | -1.87M | -2.51M | -2.08M |
| Sale of Property, Plant, and Equipment | 229.00K | 229.00K | 150.00K | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -2.43M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.10M | 2.30M | 3.30M | 5.18M | 3.10M |
| Cash from Investing | 2.42M | 1.20M | 1.63M | 2.72M | -1.37M |
| Total Debt Issued | 9.86M | 8.33M | 3.87M | 2.46M | 7.60M |
| Total Debt Repaid | -4.25M | -2.51M | -898.00K | -189.00K | -- |
| Issuance of Common Stock | 7.59M | 4.62M | 5.82M | 1.20M | 1.20M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -47.00K | -5.97M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.19M | 13.37M | 11.72M | 6.35M | 5.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -931.00K | -148.00K | -2.00M | -8.42M | -7.50M |